Notice of Intent to Sole Source – PREVENTIONGENETICS LLC – laboratory genetic testing services
| Bidders ID: | NBD00159884946458793 |
|---|---|
| Due Date: | Aug 13, 2026 |
| Posted Date: | Jul 30, 2026 |
| Level of Government: | Federal |
| State: | Maryland |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Category: |
|
| Solicitation Number: | NOI-OD-26-008338 |
| Source: | Members Only |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Presolicitation (Original)
- Original Published Date: Jul 30, 2026 10:53 am EDT
- Original Response Date: Aug 13, 2026 12:00 pm EDT
- Inactive Policy: Manual
- Original Inactive Date: Aug 13, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: Q301 - REFERENCE LABORATORY TESTING
-
NAICS Code:
- 621511 - Medical Laboratories
-
Place of Performance:
Bethesda , MD 20892USA
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for a one-year base period and four one-year option periods of laboratory genetic testing services with PREVENTIONGENETICS LLC. Based on the department's review of available testing capabilities and the unique technical requirements of the protocol, no other source has been identified that can provide the combination of CLIA-certified testing, historical sample continuity, TNXB gene analysis, CAH-X characterization, and comprehensive EDS genetic testing required to meet the Government's needs. Consequently, Prevention Genetics is the only responsible source capable of providing the required services without substantial duplication of cost, disruption to ongoing research activities, and unacceptable risk to the integrity of long-term clinical research data. Due to the proprietary nature of the contractor's historical testing database, retained patient samples, and established testing methodology used throughout the study, the Government is unable to overcome the barriers to competition without incurring substantial duplication of cost and compromising the continuity and validity of ongoing research efforts.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
Notice Type: Notice of Intent
NAICS Code: 621511
PSC Code: Q301
Posted Date: 07/30/2026
Close Date: 08/13/2026 12pm EST
End User IC: Clinical Center
POC Name: Ryssa Nix
Email Address: Ryssa.nix@nih.gov
- 6011 EXECUTIVE BLVD., SUITE 503L
- BETHESDA , MD 20892
- USA
- Chris Ryssa Nix
- ryssa.nix@nih.gov
- Jul 30, 2026 10:53 am EDTPresolicitation (Original)
TRY FOR FREE
Not a GovernmentBidders Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.
